Is there a need for morphologic exam to detect relapse in AML if multi-parameter flow cytometry is employed?

Saved in:
Bibliographic Details
Published in:Leukemia 2017-11, Vol.31 (11), p.2536-2537
Main Authors: Zhou, Y, Wood, B L, Walter, R B, Becker, P S, Percival, M-E, Bar, M, Shaw, C, Gardner, K, Hendrie, P, Abkowitz, J, Appelbaum, F R, Estey, E
Format: Article
Language:English
Subjects:
631/1647/1407/1492
692/699
692/699/67/1990
692/699/67/1990/283/1897
Acute myelocytic leukemia
Cancer
Cancer recurrence
Cancer Research
Care and treatment
Critical Care Medicine
Cytodiagnosis
Cytometry
Diagnosis
Flow cytometry
Hematology
Intensive
Internal Medicine
letter-to-the-editor
Leukemia research
Medicine
Medicine & Public Health
Methods
Morphology
Oncology
Patient outcomes
Relapse
Risk factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0887-6924
1476-5551
DOI:10.1038/leu.2017.263